Investor Relations
Inventurus Knowledge Solutions Limited
Corporate Governance
Policies
- Nomination and Remuneration Policy
- Corporate Social Responsibility Policy and Composition of the CSR Committee
- Code of Conduct for Directors and Senior Managerial Personnel
- Whistle Blower Mechanism Policy
- Familiarization Programs for Independent Directors
- Archival Policy
- Policy on determination of materiality for disclosure
- Dividend Distribution Policy
- Policy on Materiality of Related Party Transaction
- Policy for Determining Material Subsidiary
- Board Diversity Policy
- Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information
- Policy and Procedure for Inquiry in Case of Leak of Unpublished Price Sensitive Information
- Code of Conduct to regulate, monitor and report trading by Designated Persons
Other Disclosures
SEBI Disclosures
Disclosures
- IKS Health Wins Additional Top Honors in 2025 Black Book Surveys in Clinical Documentation and Medical Coding
- IKS Health Wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
- Disclosure under Regulation 30 of SEBI LODR Regulations, 2015 – Order from Reserve Bank of India, Central Office, Mumbai dated March 4, 2025
- Schedule of Analyst/ Institutional Investor Meet – Intimation dated February 21, 2025
- Schedule of Analyst/ Institutional Investor Meet – Intimation dated February 15, 2025
- Newspaper advertisement confirming dispatch of Postal Ballot Notice dated February 9, 2025
- Outcome of the Board Meeting held on February 5, 2025
- Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Order from Reserve Bank of India, Central Office, Mumbai dated January 28, 2025
- Intimation of Earnings Conference Call – Disclosure under SEBI Listing Regulations dated January 22, 2025
- Disclosure under Regulation 30 of SEBI LODR Regulations, 2015 – Order from Reserve Bank of India, Central Office, Mumbai dated January 20, 2025
- Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 dated 16 January 2025
- Shareholding Pattern as on December 31, 2024
- Intimation of closure of Trading Window dated December 27, 2024
- Intimation pursuant to Regulation 8(1) and 8(2) of the SEBI PIT Regulations dated December 19, 2024
- Disclosure under Regulation 30(5) of the SEBI LODR dated December 19, 2024
Key Documents
Material Contracts to the Offer
Material Documents
- Certificate of Incorporation and Memorandum and Articles of Association
- Resolution of the Board of Directors approving the Offer
- Resolutions of the Board of Directors taking on record the consent of the Selling Shareholders to participate in the Offer for Sale
- Resolutions of the Board of Directors and IPO Committee approving the DRHP
- Resolutions of the Board of Directors approving RHP
- Resolution for approval of Prospectus
- Resolution passed by the Audit Committee approving the KPIs
- Annual reports for last three years
- Subscription and Shareholders agreement and its amendments
- Transaction agreement and plan of merger
- Employment agreement between Sachin Gupta and IKS Inc.
- Consent from the Selling Shareholders
- ICA Certificate on Statement of possible special tax benefits
- The examination report on the RFS
- The report on the compilation of Proforma Financial Information
- Consent of Statutory Auditors
- Consent of Independent Chartered Accountant
- Consents
- ICA Certificate on Basis for Offer Price and KPIs
- ICA Certificate confirming the weighted average price
- ICA Certificate on acquisition of security
- ICA Bring Down Certificate
- Zinnov Industry Report and consent
- In-principle approvals from BSE
- In-principle approvals from NSE
- Tripartite Agreement between our Company, NSDL and the RTA
- Tripartite Agreement between Company, CDSL and the RTA
- Due diligence certificate
- SEBI interim observations letter
- SEBI final observation letter
Investor Contact Details
Sameer Chavan, Company Secretary and Compliance Officer
Inventurus Knowledge Solutions Limited
Address : 801, Building No.5&6, 8th Floor,
Mindspace Business Park (SEZ)
Thane-Belapur Road, Airoli, Navi Mumbai – 400708
Thane, Maharashtra, India
Tel: +91-22-3964-3205
Email: company.secretary@ikshealth.com
Website: www.ikshealth.com
CIN : U72200MH2006PLC337651
GST NO : 27AABCI5573J1ZA
Details of Registrar and Share Transfer Agents
MUFG Intime India Private Limited
C-101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai 400 083
Maharashtra, India
Tel: +91 810 811 4949
Email: ikshealth.ipo@linkintime.co.in
Website: www.linkintime.co.in
Investor grievance email: ikshealth.ipo@linkintime.co.in
Contact person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058